Company
Company

Relevant Interviews, Disease and Trial Updates and Stock-Markets News posted by CRISPR Medicine News.

Check also Companies to Follow in 2022 and CMN Markets for the latest stock and market trends.

Always stay updated with the free CMN Newsletter.

iECURE

Main focus: Treatment of genetic diseases using in vivo gene editing

Company stage: Pre-clinical

Diseases (gene editing): Liver diseases, other genetic diseases

Genome editing tool: ARCUS Meganuclease

Funding stage: Private

Location: Philidelphia, PA, USA

Website: https://iecure.com/

Gene editing partnerships: Precision Biosciences

iECURE develops novel medicines to treat liver diseases and other genetic diseases. The company has licensed Precision Biosciences' ARCUS Meganuclease gene-editing technology for the development of treatments targeting the PCSK9 gene as well as other targets.

Tags

HashtagiECURE

Company: iECURE
Jobs, banner ads, webinars, sponsored content...
close
Search CRISPR Medicine